DaunoXome® (Liposomal Daunorubicin) is an anthracycline, indicated for use in Kaposi’s Sarcoma. Besides the approved indication, Daunoxome® has been extensively studied in various haematological malignancies such as Acute Myeloid Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL).

For more information on DaunoXome®
Please refer https://www.galen-pharma.com/products/daunoxome or
Contact your local sales representative or
Email us at info@sayretherapeutics.com

Daunoxome by Galen